Drug Profile
Goserelin intranasal - West Pharmaceutical Services
Latest Information Update: 25 Nov 2021
Price :
$50
*
At a glance
- Originator West Pharmaceutical Services Drug Delivery and Clinical Research Centre
- Class Antineoplastics; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Endometriosis
Most Recent Events
- 20 Jun 2001 No-Development-Reported for Endometriosis in United Kingdom (Intranasal)
- 26 Jan 2001 DanBioSyst is now called West Pharmaceutical Services Drug Delivery and Clinical Research Centre
- 08 Jul 1998 Preclinical development for Endometriosis in United Kingdom (Intranasal)